Cargando…
Type 1 diabetes mellitus following COVID‐19 RNA‐based vaccine
The epidemic of coronavirus disease‐2019 (COVID‐19) is the major public health issue in the world. COVID‐19 vaccines are one of the most effective strategies against COVID‐19. Here we report a 36‐year‐old female patient who had thirst, polydipsia, polyuria, palpitations, loss of appetite, and fatigu...
Autores principales: | Sakurai, Kanako, Narita, Daiki, Saito, Naomi, Ueno, Takayuki, Sato, Ryota, Niitsuma, Satsuki, Takahashi, Kazuhiro, Arihara, Zenei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114989/ https://www.ncbi.nlm.nih.gov/pubmed/35220662 http://dx.doi.org/10.1111/jdi.13781 |
Ejemplares similares
-
Studies on anti-rabphilin-3A antibodies in 15 consecutive patients presenting with central diabetes insipidus at a single referral center
por: Arihara, Zenei, et al.
Publicado: (2022) -
Effect of anions or foods on absolute bioavailability of calcium from calcium salts in mice by pharmacokinetics
por: Ueda, Yukari, et al.
Publicado: (2013) -
Immunogenicity of SARS-CoV-2 mRNA intramuscular vaccination in patients with muscular disorders
por: Kasai, Ryousuke, et al.
Publicado: (2023) -
Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022) -
Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination
por: Aydoğan, Berna İmge, et al.
Publicado: (2022)